Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Maxar Technologies Inc is a communication equipment business based in the US. Maxar Technologies shares (MAXR) are listed on the NYSE and all prices are listed in US Dollars. Maxar Technologies employs 4,300 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$29.93|
|52-week range||$21.03 - $58.70|
|50-day moving average||$29.74|
|200-day moving average||$33.42|
|Wall St. target price||$42.86|
|Dividend yield||$0.04 (0.13%)|
|Earnings per share (TTM)||$0.09|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||1.22%|
|1 month (2021-09-22)||1.29%|
|3 months (2021-07-22)||-13.90%|
|6 months (2021-04-22)||-21.81%|
|1 year (2020-10-22)||1.22%|
|2 years (2019-10-22)||268.60%|
|3 years (2018-10-22)||30.95|
|5 years (2016-10-18)||N/A|
Valuing Maxar Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Maxar Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Maxar Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 332x. In other words, Maxar Technologies shares trade at around 332x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Maxar Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $391 million.
The EBITDA is a measure of a Maxar Technologies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.8 billion|
|Operating margin TTM||4.24%|
|Gross profit TTM||$730 million|
|Return on assets TTM||1.05%|
|Return on equity TTM||-0.64%|
|Market capitalisation||$2.1 billion|
TTM: trailing 12 months
There are currently 5.5 million Maxar Technologies shares held short by investors – that's known as Maxar Technologies's "short interest". This figure is 11.7% down from 6.2 million last month.
There are a few different ways that this level of interest in shorting Maxar Technologies shares can be evaluated.
Maxar Technologies's "short interest ratio" (SIR) is the quantity of Maxar Technologies shares currently shorted divided by the average quantity of Maxar Technologies shares traded daily (recently around 619104.64326161). Maxar Technologies's SIR currently stands at 8.83. In other words for every 100,000 Maxar Technologies shares traded daily on the market, roughly 8830 shares are currently held short.
However Maxar Technologies's short interest can also be evaluated against the total number of Maxar Technologies shares, or, against the total number of tradable Maxar Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Maxar Technologies's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Maxar Technologies shares in existence, roughly 80 shares are currently held short) or 0.0772% of the tradable shares (for every 100,000 tradable Maxar Technologies shares, roughly 77 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Maxar Technologies.
Find out more about how you can short Maxar Technologies stock.
We're not expecting Maxar Technologies to pay a dividend over the next 12 months.
Over the last 12 months, Maxar Technologies's shares have ranged in value from as little as $21.0273 up to $58.7024. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Maxar Technologies's is 1.3243. This would suggest that Maxar Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Maxar Technologies Inc. provides earth intelligence and space infrastructure solutions in the United States, Asia, South America, Europe, the Middle East, Australia, Canada, and internationally. It operates through Earth Intelligence and Space Infrastructure segments. The Earth Intelligence segment offers earth imagery products, including orthorectified imagery, imagery basemap, 3D and elevation, and information products; and SecureWatch, a subscription offering that provides online access to imagery and geospatial intelligence platform. This segment also offers geospatial information, application, and analytic services. It serves U. S.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.